SPRY News

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving ARS Pharmaceuticals, Inc. – SPRY

SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?

ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Contact Levi & Korsinsky to Join Class Action Before October 5, 2026

Robbins LLP Reminds Investors of the Securities Fraud Class Action Lawsuit Against ARS Pharmaceuticals Inc. Following a More Than 23% Stock Drop on June 25, 2026

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against ARS Pharmaceuticals, Inc. – SPRY

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders

SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors Have Opportunity to Lead Class Action Lawsuit!